The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices

Helix Biopharma Corp closed at $1.92.

Although unchanged over the last five days, shares are down 4.00% for the last year to date. This security has underperformed the S&P TSX by 17.54% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.11
Updated at previous session's close. Delayed by at least 15 minutes.

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in $ millions unless otherwise notedApr 30, 201604/30/2016Jan 31, 201601/31/2016Oct 31, 201510/31/2015Jul 31, 201507/31/2015
Revenue0------
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense2232
Selling / general / administrative1111
Research & development1111
Depreciation / amortization0000
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-2-2-3-2
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-2-2-3-2
Income after tax-2-2-3-2
Income tax, total------0
Net income-2-2-3-2
Total adjustments to net income--------
Net income before extra. items-2-2-3-2
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-2-2-3-2
Inc. avail. to common incl. extra. items-2-2-3-2
Diluted net income-2-2-3-2
Dilution adjustment--------
Diluted weighted average shares85858585
Diluted EPS excluding extraordinary itemsvalue per share-0.03-0.03-0.03-0.03
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.03-0.03-0.03-0.03